.png)
Higher levels of SDMA and not ADMA are associated with poorer survival of trial patients with systemic ANCA-associated vasculitis
Uta Erdbrügger, Jan T. Kielstein, Kerstin Westman, Jennie Z. Ma, Wenjun Xin, Stephanie M. Bode-Böger, Mȧrten Segelmark, Niels Rasmussen, Kirsten de Groot
(Eur J Rheumatol 2018; 5: 153-159) DOI: 10.5152/eurjrheum.2018.17119